Fig. 7. Intrapatient variation in key contact signatures for PGDM1400 and PGT121. Intrapatient variation in key contact signatures for PGDM1400 and PGT121.

Slides:



Advertisements
Similar presentations
Fig. 1 CSF1 is increased in blood of melanoma patients and correlates with disease progression. CSF1 is increased in blood of melanoma patients and correlates.
Advertisements

Fig. 8. Recurrent copy number amplification of BRD4 gene was observed across common cancers. Recurrent copy number amplification of BRD4 gene was observed.
Fig. 1. NS1 protein alignment and linear epitope mapping of the 10 antibodies used to run the DENV serotype–specific NS1 rapid tests, pan-DENV NS1 test,
Examples of functional imaging biomarkers in two DCA responders
Fig. 1. Generation of ERY974. Generation of ERY974. (A) Schematic illustration of ERY974 structure and the introduced mutations. The two Fab arms share.
Fig. 5. Protective efficacy of the combination of PGT121 + PGDM1400 against a mixed SHIV challenge in rhesus monkeys. Protective efficacy of the combination.
Fig. 3 Urinary LAM concentration predicted pulmonary TB and correlated to mycobacterial burden and weight loss. Urinary LAM concentration predicted pulmonary.
Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.
Fig. 3. Structure of ALS-associated RNA binding proteins.
Fig. 4 Bacterial taxonomic groups that discriminate among RYGB-, SHAM-, and WMS-derived samples. Bacterial taxonomic groups that discriminate among RYGB-,
Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.
Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
β-ARs signal cooperatively with mutant EGFR and inactivate LKB1
Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.
Fig. 2. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral blood. Engraftment of CART-EGFRvIII and cytokine modulation in the peripheral.
Fig. 2. Associations between bacterial taxa abundance ascertained by fecal shotgun metagenomic sequencing and the fecal metabolome in healthy pediatric.
Fig. 1 Crohn’s disease association within the LRRK2 locus.
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 3. Frequencies of amino acids at critical PGT121 and contact sites in the SHIV-SF162P3 challenge stock. Frequencies of amino acids at critical.
Fig. 2 Maraba treatment results in complete responses in the window of opportunity setting. Maraba treatment results in complete responses in the window.
Fig. 1 DMF promotes viral infection.
Fig. 2. GPC3 expression in normal and tumor tissues.
Increased ADMA in pregnancy is associated with SGA birth outcomes
Fig. 4. In vivo analysis of slpA mutant in the Syrian Golden hamster.
Fig. 5 Analysis of metabolite changes in M
Dot plots of trisomic versus fetal fractions for cohorts 1 and 2
Immunofluorescence staining of virus-infected human placental explants
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Fig. 3. Applying the rapid test to analyze human patient sera.
Fig. 6. Epitope mapping of C12G6.
Fig. 4. MATE1 transcription in RCC.
Fig. 6. Safety assessment in cynomolgus monkey.
Fig. 1. Mutations in slpA confer Av-CD291.2 resistance.
Fig. 3 ROC curves of mCCNA1 and mVIM assayed in esophageal cytology brushings from control normal-appearing GE junctions versus BE and EAC cases. ROC curves.
Fig. 6 ROC curves of mCCNA1 and mVIM assayed on esophageal balloon samplings of the distal esophagus. ROC curves of mCCNA1 and mVIM assayed on esophageal.
Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.
Fig. 4 Nanocages captured multiple TB-related analytes.
Fig. 4 Phylogeny of rabies strains isolated during and after the mass vaccination campaign. Phylogeny of rabies strains isolated during and after the mass.
Fig. 4. Actin polymerization rhythms are required for circadian regulation of adhesion and wound-healing efficacy by fibroblasts. Actin polymerization.
Antiproliferative effects of JQ-EZ-05 on VHL−/− ccRCC are on-target
Fig. 3. Recovery of AVP-deficient rats from anemia induced by sublethal irradiation. Recovery of AVP-deficient rats from anemia induced by sublethal irradiation.
Fig. 3. The effects of DCA on hemodynamic and functional end points and their association with genetic factors (variants of the SIRT3 and UCP2 genes) that.
Fig. 2 Identification of the candidate AvrSr35 gene.
Fig. 7. Inhibitory mechanisms of C12G6.
Fig. 7 Improvement of clinical score and axon pathology by nasal IL-4 treatment during chronic EAE. Improvement of clinical score and axon pathology by.
Fig. 1. In vitro binding and neutralization activities of C12G6.
Comparison of therapeutic efficacies of C12G6 and other bnAbs in mice
Fig. 1 A single amino acid difference in the ATP-binding domain of GSK3α and GSK3β results in structural and topological differences. A single amino acid.
Fig. 1 Effect of preinfection β7Hi CD45RA−CD4+ T cell frequency on HIV acquisition risk in CAPRISA 004 study. Effect of preinfection β7Hi CD45RA−CD4+ T.
Fig. 4. The effect of single-dose rozanolixizumab on the concentration of IgG subtypes in healthy subjects. The effect of single-dose rozanolixizumab on.
Fig. 4. Efficacy of C12G6 compared with and in combination with oseltamivir in mice. Efficacy of C12G6 compared with and in combination with oseltamivir.
Fig. 6. Analysis of SHIV-325c V1V2 envelope sequences in breakthrough infections. Analysis of SHIV-325c V1V2 envelope sequences in breakthrough infections.
Fig. 3 FMAEs promote infection by VSVΔ51.
Fig. 1. In vivo fates of patient-derived AML cells defined by mutational profile. In vivo fates of patient-derived AML cells defined by mutational profile.
Fig. 6. CXM correlates with age and growth velocity.
Fig. 5. Mapping of HBV S transcripts from HBeAg-positive and HBeAg-negative chimpanzees. Mapping of HBV S transcripts from HBeAg-positive and HBeAg-negative.
Fig. 5. Prophylactic and therapeutic efficacy of C12G6 in ferrets.
Fig. 3 CSF1 is expressed in human melanoma.
Fig. 7 Analysis of the bacterial nidus within tissue abscesses by MALDI IMS demonstrates a paucity of calprotectin signal. Analysis of the bacterial nidus.
Fig. 7 Vaccine-induced influenza-specific B cells are not maintained in peripheral blood. Vaccine-induced influenza-specific B cells are not maintained.
Vaccination induces activation of cTFH cells and transient ASCs
IIV induces CD21hiCD27+ and CD21loCD27+ influenza-specific B cells
Fig. 5 Early and modest immune response at day 3 after exposure in Delayed animals. Early and modest immune response at day 3 after exposure in Delayed.
Correlation of reovirus RNA/protein with proliferating tumor cells
Fig. 5. Rises in RSV PRNT during the surveillance period.
Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.
Fig. 2 Dynamics of Nef-stop repair and predictors of viral set-point.
Fig. 3 Characterization of SGN responses to optogenetic stimulation.
Fig. 3. Association between peak CTL019 expansion and response.
Presentation transcript:

Fig. 7. Intrapatient variation in key contact signatures for PGDM1400 and PGT121. Intrapatient variation in key contact signatures for PGDM1400 and PGT121. Logo plots of viral sequence diversity in the key PGDM1400 and PGT121 contact sites (figs. S8 to S10) in 10 HIV-1–infected individuals for whom >150 full-length env sequences were available in the Los Alamos Sequence Database. The subject ID is indicated above each plot. The x axis indicates the amino acid position based on HXB2 numbering. The y axis indicates the probability of an amino acid at this location. O indicates an Asn that is part of a PNGS. Blue reflects sensitivity signatures, red reflects resistance signatures, and black reflects no statistically significant associated with antibody sensitivity. Boris Julg et al., Sci Transl Med 2017;9:eaao4235 Published by AAAS